Keyphrases
Multiple Myeloma
92%
Myeloma Cells
73%
Bone Marrow
45%
Myelodysplastic Syndrome
43%
Deferasirox
40%
Human Mesenchymal Stem Cells (hMSCs)
34%
Lenalidomide
33%
Graft-versus-host Disease (GvHD)
33%
Histone Deacetylase Inhibitor (HDACi)
28%
Iron Chelator
27%
Liposomal
26%
Myeloid Neoplasms
26%
Endoplasmic Reticulum Stress (ER stress)
26%
Synergistic Cytotoxicity
26%
Successful Treatment
26%
Cisplatin
26%
Older Men
26%
Carfilzomib
25%
Induced Apoptosis
25%
Diffuse Large B-cell Lymphoma (DLBCL)
25%
Tumor
23%
Rituximab
22%
Hepatocellular Carcinoma
22%
Bortezomib
22%
Cell Growth
21%
Mesenchymal Stromal Cells
21%
Leukemic Cells
21%
Myeloma
20%
Buried Bumper Syndrome
20%
Endoscopic Submucosal Dissection
20%
Transabdominal
20%
Docetaxel
20%
CD34+
18%
Hedgehog Signaling
18%
Stem Cell Factor
18%
Histone Deacetylases
17%
Monotherapy
17%
Complete Response
16%
Metastasis
16%
Anemia
16%
Selective Inhibitor
16%
Serum Ferritin
16%
Hedgehog Inhibitor
16%
Chemotherapy
15%
Acute Myeloid Leukemia
15%
Hippo Pathway
15%
Etiology
15%
Iron Deficiency Anemia
15%
Hedgehog Proteins
15%
Apoptosis
15%
Medicine and Dentistry
Multiple Myeloma
80%
Neoplasm
69%
Cytotoxicity
37%
Hepatocellular Carcinoma
33%
Myeloma Cell
30%
Myelodysplastic Syndrome
30%
Outpatient
27%
Carfilzomib
27%
Metastatic Carcinoma
26%
Cell Death
26%
Histone Deacetylase
26%
Endoplasmic Reticulum Stress
26%
Pancreas Cancer
26%
Deferasirox
26%
Monotherapy
26%
Programmed Cell Death
25%
Graft Versus Host Reaction
24%
Diffuse Large B-Cell Lymphoma
24%
In Vitro
23%
Disease
21%
Hedgehog Signaling
21%
Histone Deacetylase Inhibitor
20%
Endoscopic Submucosal Dissection
20%
Proteasome
20%
Lymphoma Cell
19%
Stem Cell Factor
18%
Bone Marrow Stromal Cell
17%
Acute Graft Versus Host Disease
17%
Cell Growth
16%
Myeloma
16%
Cancer Cell
15%
Iron Chelating Agent
14%
Stromal Cell
14%
Liver Tumor
14%
Acute Myeloid Leukemia
13%
Fucose
13%
Myocardium
13%
Fucosyltransferase
13%
Follicular Lymphoma
13%
Dissecting Aortic Aneurysm
13%
Thrombomodulin
13%
Liver Hematoma
13%
Eribulin
13%
Melanocytosis
13%
Histone Deacetylase 4
13%
Magnifying Endoscopy
13%
Esophagus
13%
Carcinoma Cell
13%
Hemoperitoneum
13%
Protein Binding
13%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Cytotoxicity
53%
Deferasirox
40%
Myelodysplastic Syndrome
33%
Chemotherapy
30%
Carfilzomib
29%
Iron Chelating Agent
27%
Docetaxel
26%
Cisplatin
26%
Histone Deacetylase
26%
Abdominal Cancer
26%
Bortezomib
24%
Disease
23%
Myeloma
23%
Neoplasm
21%
Proteasome
20%
Liver Cell Carcinoma
20%
Iron Deficiency Anemia
20%
Lenalidomide
20%
Histone Deacetylase Inhibitor
20%
Hepcidin
16%
Retrospective Study
15%
Eribulin
13%
Interstitial Pneumonia
13%
Nanoparticle
13%
Dissecting Aortic Aneurysm
13%
Histone Deacetylase 4
13%
Peritoneum Metastasis
13%
Soft Tissue Sarcoma
13%
Disseminated Intravascular Clotting
13%
Amphotericin B
13%
Fucosyltransferase
13%
Focal Adhesion Kinase 2
13%
Fucose
13%
Immunoglobulin D
13%
Erythropoietin
13%
Serine Proteinase
13%
Thrombomodulin
13%
Hematologic Malignancy
13%
Pancreas Cancer
13%
Activating Transcription Factor 4
13%
Hedgehog
13%
Drug Resistance
13%
Dabrafenib
13%
Protein P53
13%
Catenin
13%
Amyloidosis
13%
Anticarcinogen
13%
Hepatitis
13%
Dexamethasone
13%